Management of venous thromboembolism in cancer patients:: ESMO Clinical Recommendations

被引：39
作者：
Mandala, M. [1 ]
Falanga, A. [2 ]
Roila, F. [3 ]
机构：
[1] Osped Riuniti Bergamo, Med Oncol Unit, I-24100 Bergamo, Italy
[2] Osped Riuniti Bergamo, Div Haematol, I-24100 Bergamo, Italy
[3] Osped S Maria Misericordia, Dept Med Oncol, Perugia, Italy
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
10.1093/annonc/mdn110
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：126 / 127
页数：2
相关论文
共 4 条
[1]   Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer [J].
Hull, Russell D. ;
Pineo, Graham F. ;
Brant, Rollin F. ;
Mah, Andrew F. ;
Burke, Natasha ;
Dear, Richard ;
Wong, Turnly ;
Cook, Roy ;
Solymoss, Susan ;
Poon, Man-Chiu ;
Raskob, Gary .
AMERICAN JOURNAL OF MEDICINE, 2006, 119 (12) :1062-1072
[2]   Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer [J].
Lee, AYY ;
Levine, MN ;
Baker, RI ;
Bowden, C ;
Kakkar, AK ;
Prins, M ;
Rickles, FR ;
Julian, JA ;
Haley, S ;
Kovacs, MJ ;
Gent, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (02) :146-153
[3]   Venous thromboembolism and cancer:: Guidelines of the Italian Association of Medical Oncology (AIOM) [J].
Mandala, M. ;
Falanga, A. ;
Piccioli, A. ;
Prandoni, P. ;
Pogliani, E. M. ;
Labianca, R. ;
Barni, S. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 59 (03) :194-204
[4]   Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer - A randomized controlled study [J].
Meyer, G ;
Marjanovic, Z ;
Valcke, J ;
Lorcerie, B ;
Gruel, Y ;
Solal-Celigny, P ;
Le Maignan, C ;
Extra, JM ;
Cottu, P ;
Farge, D .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (15) :1729-1735
1